
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Sentimental tree to shine at Arctic League annual broadcast - 2
Terminal cancer diagnosis announced by JFK's granddaughter - 3
Artemis II astronauts race to set a new distance record from Earth and behold the moon's far side - 4
Figure out How to Pick a SUV with Senior-Accommodating Tech Elements - 5
Discovering a sense of harmony: Individual Accounts of Reflection and Care
UPM Adhesive Materials plans new facility near New Delhi, India
The Most Moving TED Talks You Want to Watch
What we know about the Brown University shooting suspect who was found dead, and how police linked him to the MIT killing
Hubble Space Telescope spies dusty debris from two cosmic collisions
Congress is running out of time to extend ACA subsidies as the GOP moves on to an alternative plan. Here's where things stand.
Israeli strikes in Gaza kill 25 people, Hamas health authority says
Instructions to Construct an Organization While Chasing after a Web-based Degree
What are parents to do as doctors clash with Trump administration over vaccines?
Defense Minister Katz finally condemns Jewish extremist violence against Palestinians












